Skip to main content
Top

Current Cardiology Reports

Issue 11/2015

Content (14 Articles)

Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies

  • Hypertension (WB White and AJ Peixoto, Section Editors)

Samuel J. Mann

The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient

  • Hypertension (WB White and AJ Peixoto, Section Editors)

Beje Thomas, Matthew R. Weir

An Update on Inpatient Hypertension Management

  • Hypertension (WB White and AJ Peixoto, Section Editors)

R. Neal Axon, Mason Turner, Ryan Buckley

Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk?

  • Hypertension (WB White and AJ Peixoto, Section Editors)

Eamon Dolan, Eoin O’Brien

What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease?

  • Hypertension (WB White and AJ Peixoto, Section Editors)

Gopesh K. Modi, Rajiv Agarwal

Prognostic and Therapeutic Implications of Frailty in Older Adults with Heart Failure

  • Heart Failure (MR Mehra and E Joyce, Section Editors)

Michael Goldfarb, Richard Sheppard, Jonathan Afilalo

Emerging Advances in the Management of Cardiac Amyloidosis

  • Heart Failure (MR Mehra and E Joyce, Section Editors)

Michael N. Vranian, Brett W. Sperry, Jason Valent, Mazen Hanna

Autonomic Modulation in Heart Failure: Ready for Prime Time?

  • Heart Failure (MR Mehra and E Joyce, Section Editors)

Mark E. Dunlap, Anju Bhardwaj, Paul J. Hauptman

Management of Aortic Aneurysms: Is Surgery of Historic Interest Only?

  • Peripheral Vascular Disease (MR Jaff, Section Editor)

J. Michael Bacharach, Emily A. Wood, David P. Slovut

EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes

  • Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Pamela Ouyang, Sheldon H. Gottlieb, Valerie L. Culotta, Ana Navas-Acien

CVD Prevention Through Policy: a Review of Mass Media, Food/Menu Labeling, Taxation/Subsidies, Built Environment, School Procurement, Worksite Wellness, and Marketing Standards to Improve Diet

  • Open Access
  • Public Health Policy (TA Gaziano, Section Editor)

Ashkan Afshin, Jose Penalvo, Liana Del Gobbo, Michael Kashaf, Renata Micha, Kurtis Morrish, Jonathan Pearson-Stuttard, Colin Rehm, Siyi Shangguan, Jessica D. Smith, Dariush Mozaffarian

Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future

  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Evan A. Stein, Frederick J. Raal

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME